A New Era in the Hemophilia Treatment : Lights and Shadows !

At the beginning of 90s’, recombinant FVIII/FIX concentrates were introduced in the hemophilia therapy and in the following 20 years they underwent a progressive improvement of their characteristics, moving from 1st to 2nd and finally to 3rd generation. A new era of recombinant clotting factor concentrates has started since 2010, when new methods were… CONTINUE READING